<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Reversible <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> syndrome (RLS) is an <z:hpo ids='HP_0011009'>acute</z:hpo> neurological syndrome associated with <z:e sem="disease" ids="C0278061" disease_type="Mental or Behavioral Dysfunction" abbrv="">altered mental status</z:e> and visual disturbances described in patients with sudden elevations in systemic blood pressure and other medical conditions </plain></SENT>
<SENT sid="1" pm="."><plain>In this process, neuroimaging studies usually demonstrate diffuse <z:hpo ids='HP_0000969'>edema</z:hpo> involving the subcortical structures of the posterior regions of the brain </plain></SENT>
<SENT sid="2" pm="."><plain>Triple H (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHH</z:e>) therapy is an established treatment for symptomatic vasospasm following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="3" pm="."><plain>RLS has not been reported in the scientific literature as a complication of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHH</z:e> therapy with perfusion computed tomography (<z:chebi fb="22" ids="17677">CTP</z:chebi>) imaging documentation </plain></SENT>
<SENT sid="4" pm="."><plain>CASE: A 73-year-old woman developed iatrogenic RLS during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHH</z:e> therapy for SAH-related vasospasm </plain></SENT>
<SENT sid="5" pm="."><plain>The computed tomography (CT) revealed bilateral parieto-occipital hypodensities </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="22" ids="17677">CTP</z:chebi> study showed increased cerebral blood volume and blood flow as well as decreased mean transit time in both parietal-occipital regions, which is compatible with vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The induction of <z:hpo ids='HP_0000822'>hypertension</z:hpo> as part of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHH</z:e> therapy for SAH-related <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> may result in RLS </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, it should be considered as a potentially reversible cause in the differential diagnosis of neurological deterioration in SAH patients while on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HHH</z:e> therapy </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="22" ids="17677">CTP</z:chebi> study can offer an alternative for the assessment of this cerebrovascular syndrome </plain></SENT>
</text></document>